- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Emcure Pharmaceuticals has announced a board meeting approving the re-appointment of Dr. Mukund Gurjar as Whole-time Director for one year from August 28, 2025, subject to member approval. With over two decades at the company and extensive scientific expertise, Dr. Gurjar’s continued leadership strengthens Emcure’s operational stability and innovation capacity, supporting its strategic growth and R&D initiatives.